CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
Kontigo Care is developing Previct Drugs, an app-based platform for continuous self-monitoring of drug use through video analysis of eye biomarkers. This eHealth solution aims to enhance addiction management by providing real-time feedback and support to users.
Drug addiction is a global problem; nearly 30 million illicit drug users worldwide suffer from problematic drug use.
Kontigo Care AB is developing an innovative medical device – Previct Drugs - a robust, app-based, eHealth-platform for place unbound, continuous, voluntary, self-monitoring of drug use.
It will constitute an add-on to Kontigo Care’s current eHealth offer developed for management of other addictive disorders (alcohol abuse and hazard gambling).
Using smartphone cameras, patients s…
KONTIGO CARE AB
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
